The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2020
Filed:
Jul. 15, 2016
Applicant:
The Global Alliance for Tb Drug Development, Inc., New York, NY (US);
Inventors:
Christopher B. Cooper, New York, NY (US);
Haihong Huang, New York, NY (US);
Dongfeng Zhang, New York, NY (US);
Nader Fotouhi, New York, NY (US);
Takushi Kaneko, New York, NY (US);
Assignee:
The Global Alliance for TB Drug Development, Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 263/20 (2006.01); C07D 263/24 (2006.01); A61K 31/422 (2006.01); A61K 45/06 (2006.01); A61K 31/554 (2006.01); C07D 491/107 (2006.01); C07D 495/10 (2006.01); C07D 498/08 (2006.01); A61P 31/06 (2006.01); A61K 31/5386 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 491/08 (2006.01); C07D 495/08 (2006.01);
U.S. Cl.
CPC ...
C07D 263/20 (2013.01); A61K 31/422 (2013.01); A61K 31/5386 (2013.01); A61K 31/554 (2013.01); A61K 45/06 (2013.01); A61P 31/06 (2018.01); C07D 263/24 (2013.01); C07D 413/06 (2013.01); C07D 413/12 (2013.01); C07D 491/08 (2013.01); C07D 491/107 (2013.01); C07D 495/08 (2013.01); C07D 495/10 (2013.01); C07D 498/08 (2013.01);
Abstract
The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treatingand other microbial infections, either alone or in combination with other anti-infective treatments.